Cathie Wood Invests in Block Stock, Sells Shopify Shares Amid Market Volatility

Cathie Wood's ARK Invest ETFs bought $19.2 million worth of Block stock, while selling $10.3 million worth of Shopify shares. Wood also sold shares of Guardant Health and continued accumulating shares of CRISPR Therapeutics, Personalis, and Compass Pathways. The move is notable as Wood had recently been offloading Block stock, but the company's shares have surged nearly 33% over the past three months.

Cathie Wood's ARK Invest ETFs made substantial moves in the stock market on Monday, August 12, 2025. The fund bought $19.2 million worth of Block Inc. (NYSE:XYZ) shares while selling $10.3 million worth of Shopify Inc. (NASDAQ:SHOP) shares. Additionally, Wood sold shares of Guardant Health Inc. (NASDAQ:GH) and continued accumulating shares of CRISPR Therapeutics AG (NASDAQ:CRSP), Personalis Inc. (NASDAQ:PSNL), and Compass Pathways PLC (NASDAQ:CMPS).

The purchase of Block shares comes after a recent pullback in the stock's price. Block Inc. has seen its shares surge nearly 33% over the past three months, despite missing analyst consensus estimates for its second-quarter earnings. The company reported quarterly earnings of 62 cents per share, falling short of the expected 68 cents. However, the stock has gained attention due to the momentum of its Cash App, which has been performing well.

On the other hand, Ark Invest sold 69,973 shares of Shopify, totaling approximately $10.3 million. This move could indicate a strategic shift to capitalize on Shopify's current market position. Despite positive sales figures, Ark's decision to sell shares could signal a desire to lock in profits or rebalance the portfolio.

ARKK, ARKW, and ARKF funds bought 152,980, 69,526, and 39,957 shares of Block Inc., respectively. The total value of these purchases amounted to approximately $19.2 million, calculated based on Block's last closing price of $73.03.

ARKK also sold 7,200 shares of Guardant Health Inc. and bought 1,415 shares of CRISPR Therapeutics AG. The fund purchased 59,880 shares of Personalis Inc. and 23,970 shares of Compass Pathways PLC.

These trades highlight ARK's dynamic investment strategy, focusing on innovative companies within the fintech and biotech sectors. The fund's moves provide insights into its long-term investment thesis and potential areas of growth.

References:
[1] https://finance.yahoo.com/news/cathie-wood-bets-19-million-023104379.html
[2] https://www.investing.com/news/company-news/cathie-woods-ark-makes-major-moves-in-trade-desk-and-block-stock-93CH-4184429
[3] https://coingape.com/cathie-wood-buys-262463-block-inc-shares-as-jack-dorsey-pushes-for-btc-adoption/
[4] https://finance.yahoo.com/news/cathie-wood-snaps-millions-block-175033448.html